SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cbot Holdings Inc – ‘425’ on 7/6/07 re: Cbot Holdings Inc

On:  Friday, 7/6/07, at 5:23pm ET   ·   Accession #:  1193125-7-151108   ·   File #:  1-32650

Previous ‘425’:  ‘425’ on 7/6/07   ·   Latest ‘425’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/06/07  Cbot Holdings Inc                 425                    1:71K  Cbot Holdings Inc                 RR Donnelley/FA

Business-Combination Transaction Communication   —   Rule 425
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 425         Business-Combination Transaction Communication      HTML     15K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 425  

Filed by CBOT Holdings, Inc. Pursuant to

Rule 425 under the Securities Act of 1933 and

deemed filed pursuant to Rule 14a-6 under the

Securities Exchange Act of 1934

Subject Company

CBOT Holdings, Inc.

(Commission File No. 001-32650)


LOGO

FOR IMMEDIATE RELEASE

CBOT CONFIRMS NO “EX-DIVIDEND” DATE

CHICAGO, July 6, 2007 – CBOT Holdings, Inc., holding company for the Chicago Board of Trade (CBOT®) (NYSE: BOT), one of the leading global derivatives exchanges, today confirmed that the New York Stock Exchange has not established an “ex-dividend” date in connection with the previously announced conditional special dividend that is a part of its merger with Chicago Mercantile Exchange Holdings Inc. (CME).

As previously announced, CBOT Holdings has declared a one-time, conditional special cash dividend in the amount of $9.14 per share. The payment of such dividend will be conditioned upon, and such dividend shall only become payable upon, the satisfaction or waiver of all conditions to the proposed merger between CBOT Holdings and CME set forth in their merger agreement. CBOT Holdings will pay the dividend immediately prior to the closing of the merger.

Although July 5, 2007 was set as the record date for the special dividend, CBOT Holdings has been advised by the NYSE that, since the payment of the special dividend is conditional, the NYSE will not establish an “ex-dividend” date. As a result, stockholders that sell their shares of CBOT Holdings Class A common stock on the NYSE prior to the completion of the merger with CME will lose the benefit of the special dividend. Holders of CBOT Holdings Class A common stock must hold the stock at the close of trading on the date of the closing of the merger with CME in order to receive the benefit of the special dividend.

Stockholders are encouraged to consult with their brokers or financial advisors for more information regarding these procedures.

Contacts

Media:

Maria C. Gemskie

312.341.3257

 


Harlan Loeb

Financial Dynamics

312.861.4703

Investors:

Deborah Koopman

312.789.8532

About the CBOT

As one of the leading global derivative exchanges, the Chicago Board of Trade provides a diverse mix of financial, equity and commodity futures and options-on-futures products. Building on its 159-year history, the CBOT continues to advance into the future using the strength of deep liquidity, market integrity and member-trader expertise. Using superior trading technology in both electronic and open-auction trading platforms, the CBOT provides premier customer service to risk managers and investors worldwide. For more information, visit our website at www.cbot.com.

Important Merger Information

In connection with the proposed merger of CBOT Holdings, Inc. (“CBOT Holdings”) and Chicago Mercantile Exchange Holdings Inc. (“CME”), the parties have filed relevant materials with the Securities Exchange Commission (“SEC”), including a joint proxy statement/prospectus, as supplemented, regarding the proposed transaction. INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION, AS SUPPLEMENTED, BECAUSE IT CONTAINS IMPORTANT INFORMATION. Investors may obtain a free copy of the joint proxy statement/prospectus and the supplement thereto, as well as other filings containing information about CBOT Holdings and CME, without charge, at the SEC’s website (http://www.sec.gov). Copies of the joint proxy statement/prospectus and the supplement can also be obtained without charge by directing a request to CBOT Holdings, Inc., Attention: Investor Relations, at 141 West Jackson, Chicago, Illinois 60604 or calling (312) 435-3500.

CBOT Holdings and its directors and executive officers and other members of management and employees and other CBOT members may be deemed to be participants in the solicitation of proxies from CBOT Holdings stockholders in respect of the proposed transaction. Information regarding CBOT Holdings directors and executive officers is available in CBOT Holdings’ proxy statement for its 2007 annual meeting of stockholders, dated March 29, 2007. Additional information regarding the interests of such potential participants is included in the joint proxy statement/prospectus and the other relevant documents filed with the SEC. This document shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-Looking Statements

Certain statements in this document and its attachments, if any, may contain forward-looking information regarding CBOT Holdings, CME and the combined company after the completion of the transactions that are intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the benefits of the business combination transaction involving CBOT Holdings and CME including future financial and operating results, the combined company’s plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of the management of CBOT Holdings and CME and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the failure of CBOT Holdings stockholders, CBOT members or CME


stockholders to approve the transaction; the risk that the businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not be fully realized or may take longer to realize than expected; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; social and political conditions such as war, political unrest or terrorism; general economic conditions and normal business uncertainty. Additional risks and factors are identified in the joint proxy statement/prospectus and the supplement and CBOT Holdings’ other filings with the SEC, including its Report on Form 10-K for the fiscal year ending December 31, 2006 which are available on CBOT Holdings’ website at http://www.cbot.com.

You should not place undue reliance on forward-looking statements, which speak only as of the date of this document. Except for any obligation to disclose material information under the Federal securities laws, CBOT undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this document.

# # #


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘425’ Filing    Date    Other Filings
Filed on:7/6/07425,  8-K,  DEFA14A
7/5/07425,  8-K
3/29/07DEF 14A
12/31/0610-K
 List all Filings 
Top
Filing Submission 0001193125-07-151108   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 18, 5:44:38.1pm ET